Aller au contenu principal
Accès ouvert déclaré 2014 article

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

59Citations signalées, ce qui n’est pas une note de qualité
117Institutions déclarées
25Pays d’affiliation déclarés

Rattachement africain : au, us, es, gb, de, ca, pl, jp, sg, se, dk, nl, fi, kr, vn, ch, it, ie, my, tw, fr, th, cn, by, gr. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Candidate variant association studies have been largely unsuccessful in identifying common breast cancer susceptibility variants, although most studies have been underpowered to detect associations of a realistic magnitude. We assessed 41 common non-synonymous single-nucleotide polymorphisms (nsSNPs) for which evidence of association with breast cancer risk had been previously reported. Case-control data were combined from 38 studies of white European women (46 450 cases and 42 600 controls) and analyzed using unconditional logistic regression. Strong evidence of association was observed for three nsSNPs: ATXN7-K264R at 3p21 [rs1053338, per allele OR = 1.07, 95% confidence interval (CI) = 1.04-1.10, P = 2.9 × 10(-6)], AKAP9-M463I at 7q21 (rs6964587, OR = 1.05, 95% CI = 1.03-1.07, P = 1.7 × 10(-6)) and NEK10-L513S at 3p24 (rs10510592, OR = 1.10, 95% CI = 1.07-1.12, P = 5.1 × 10(-17)). The first two associations reached genome-wide statistical significance in a combined analysis of available data, including independent data from nine genome-wide association studies (GWASs): for ATXN7-K264R, OR = 1.07 (95% CI = 1.05-1.10, P = 1.0 × 10(-8)); for AKAP9-M463I, OR = 1.05 (95% CI = 1.04-1.07, P = 2.0 × 10(-10)). Further analysis of other common variants in these two regions suggested that intronic SNPs nearby are more strongly associated with disease risk. We have thus identified a novel susceptibility locus at 3p21, and confirmed previous suggestive evidence that rs6964587 at 7q21 is associated with risk. The third locus, rs10510592, is located in an established breast cancer susceptibility region; the association was substantially attenuated after adjustment for the known GWAS hit. Thus, each of the associated nsSNPs is likely to be a marker for another, non-coding, variant causally related to breast cancer risk. Further fine-mapping and functional studies are required to identify the underlying risk-modifying variants and the genes through which they act.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
Date Crossref
18/06/2014
Éditeur
Oxford University Press (OUP)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Cancer Council VictoriaCancer Genetics (United States)Hospital Monte NarancoHospital Universitario La PazHospital La Paz Institute for Health ResearchUniversidad Autónoma de MadridSpanish National Cancer Research CentreInstitute of Cancer ResearchBreast Cancer Research FoundationBreakthroughJohanniter-Krankenhaus BonnDr. Margarete Fischer-Bosch-Institute of Clinical PharmacologyUniversity of TübingenGerman Cancer Research CenterHeidelberg UniversityDKFZ-ZMBH AllianceMount Sinai HospitalLunenfeld-Tanenbaum Research InstituteLaboratory of Molecular GeneticsUniversity of TorontoPublic Health OntarioKyushu UniversityAichi Cancer CenterMie UniversityGenome Institute of SingaporeInstitute of AgingDeutsches Konsortium für Translationale KrebsforschungKrebsregister SaarlandPomeranian Medical UniversityNational University of SingaporeNational University Health SystemNational Center for Tumor DiseasesUniversity Hospital HeidelbergUniversity Medical Centre MannheimKarolinska InstitutetNational Cancer InstituteDivision of Cancer Epidemiology and GeneticsThe Maria Sklodowska-Curie National Research Institute of OncologyUniversity of CopenhagenHerlev HospitalCopenhagen University HospitalErasmus MCErasmus MC Cancer InstituteLondon School of Hygiene & Tropical MedicineVanderbilt University Medical CenterUniversität HamburgZimmer Biomet (Netherlands)University Medical Center Hamburg-EppendorfNordLabUniversity of OuluOulu University HospitalYorkshire Cancer ResearchUniversity of SheffieldThe Netherlands Cancer InstituteSeoul National UniversityGeneral Department of Preventive MedicineCentre hospitalier universitaire de QuébecUniversité LavalRoyal Victoria Regional Health CentreMcGill University Health CentreRoyal Victoria HospitalMcGill UniversityUniversité de MontréalUniversity of California, Los AngelesBreast CenterUniversitätsklinikum ErlangenComprehensive Cancer Center ErlangenIFOMFondazione IRCCS Istituto Nazionale dei TumoriEuropean Institute of OncologyKing's College LondonGuy's and St Thomas' NHS Foundation TrustCentre for Human GeneticsUniversity of OxfordOxford BioMedica (United Kingdom)Ollscoil na Gaillimhe – University of GalwayThe University of MelbourneUniversity Malaya Medical CentreCancer Research MalaysiaSubang Jaya Medical CentreSingapore National Eye CenterSingapore Eye Research InstituteChina Medical UniversityInstitute of Biomedical Sciences, Academia SinicaTri-Service General HospitalKaohsiung Medical University Chung-Ho Memorial HospitalUniversité Paris-SudInsermCentre de recherche en Epidémiologie et Santé des PopulationsEpigénétique et Destin CellulaireVanderbilt UniversityUniversity of HelsinkiHelsinki University HospitalUniversity of Southern CaliforniaMedizinische Hochschule HannoverUniversity of ManchesterUniversity of WarwickMinistry of Public HealthInstitute of Clinical ResearchBiocenter FinlandUniversity of Eastern FinlandKuopio University HospitalShanghai Municipal Center For Disease Control PreventionShanghai Cancer InstituteDepartment of Medical SciencesThe Ohio State UniversityNational Centre of Scientific Research "Demokritos"National Cancer Institute of ThailandCentre international de recherche sur le cancerUniversity of Hawaiʻi at MānoaUniversity of Hawaii SystemCancer Center of HawaiiUniversity of Hawaii Cancer CenterLeiden University Medical CenterUniversity of CambridgeCancer Research UK Cambridge CenterQIMR Berghofer Medical Research Institute

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

BRCA gene mutations in cancerGenetic Associations and EpidemiologyNutrition, Genetics, and Disease

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.